Position in BIIB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$38,461,272
+$5,819,549 QoQ
Shares Held
178,012
-0.0% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#77
of 1,036 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Derivatives in BIIB
reported options exposure · as of Mar 31, 2024CallValue
$0
CallShares
0
PutValue
$21,563
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Allianz Asset Management GmbH holds $5,256,144,156 across 13 Drug Manufacturers - General names. BIIB ranks #10 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
6,830,190 | $1,295,140,626 | |
| 2 | JNJ |
Johnson & Johnson
|
4,873,739 | $1,237,783,491 | |
| 3 | LLY |
ELI LILLY & Co
|
477,197 | $572,364,441 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,713,343 | $477,164,575 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,275,402 | $476,828,662 | |
| 6 | ABBV |
AbbVie Inc.
|
1,566,077 | $394,087,615 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,853,184 | $360,471,266 | |
| 8 | AMGN |
Amgen Inc
|
636,542 | $230,504,586 |
All Filings in BIIB
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,461,272 | 178,012 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $32,641,723 | 178,049 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $43,596,594 | 247,722 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $55,584,164 | 396,803 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $66,193,464 | 527,060 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $91,377,235 | 667,767 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $81,958,084 | 535,954 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $101,865,439 | 525,513 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $122,442,222 | 528,178 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $21,563 | 100 | Put | Defined | 2024-05-14 | |
| 2024-03-31 | $133,743,212 | 620,244 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $185,982,914 | 718,719 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $198,503,727 | 772,358 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $214,267,302 | 752,211 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $194,417,759 | 699,269 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $161,066,086 | 581,634 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $150,836,577 | 564,931 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $121,891,877 | 597,685 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $111,782,688 | 530,782 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $112,251,128 | 467,869 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $88,299,670 | 312,024 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $70,064,617 | 202,341 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $65,187,623 | 233,021 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $86,816,091 | 354,554 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $86,946,784 | 306,496 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $162,123,525 | 605,956 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $184,340,070 | 582,654 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||